The future is now: AI-enabled RNA–LNP discovery

Bowen Li

11 April 2025

Interview

Novel srRNA vectors for customizable vaccine development

D S Spasova, S J Miyake-Stoner, G Picarda et al

10 April 2025

Short Communication

Next-level LNP formulation with the Sunny Suite

Benjamin Knappett

26 March 2025

Watch

Key considerations for successful clinical development of mRNA therapeutics

26 March 2025

Infographic

Sharpen up your RNA and LNP quant with Stunner

Kevin Lance

19 March 2025

Watch

For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

Stanley Crooke

12 March 2025

Interview

Solving unique analytical challenges in mRNA-LNP bioprocessing with precise measurement methods

Nigel Herbert

11 March 2025

Watch

Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

Ketaki Deshmukh

19 February 2025

Podcast

Biopharmaceutical Analytics Unveiled: Expert Insights and Customer Success Stories

09 December 2024

Conference Insight

Improving lipid nanoparticle formulations for targeted delivery of genome editors

Rohit Sharma

05 November 2024

Interview

Potential use of lipid nanoparticles in non-vaccine therapeutics

Nagy Habib

22 October 2024

Viewpoint

Elevate LNP optimization with Sunshine and Stunner

Kevin Lance

17 October 2024

Watch

Engineering lipid nanoparticles for lung cancer imaging

Ben Knappett, Blaine McCarthy

03 October 2024

Watch

Optimized and scalable LNP composition for RNA vaccine delivery

Martin Rabel

25 September 2024

Watch

Advancing delivery of RNA therapeutics with cationizable xenopeptides

Ernst Wagner

24 September 2024

Interview

Addressing the challenge of screening DNA-LNP formulations for targeting the brain

Razieh Karamzadeh, Benjamin Knappett

12 September 2024

Watch

Unlocking mRNA-LNP potential using a novel lipid library combined with innovative analytical methods

Nejc Pavlin, Guillaume Freund

11 September 2024

Watch

Revolutionizing in vivo genome editing with targeted, non-viral delivery

Joseph Nabhan, Gary Hao, Qin Yu

11 September 2024

Viewpoint

Delving into the unknowns of mRNA-LNP formulation and characterization

Ramesh Marasini

15 July 2024

Interview

Taking a high-throughput approach to enhancing the target specificity and stability of nanoparticles

Chun-Wan Yen, Yuchen Fan

20 June 2024

Interview

Simplifying the transition from R&D to GMP-ready LNP production

Benjamin Knappett

16 May 2024

Watch